Rubicon Research Listed on NSE
Mumbai-based pharmaceutical formulations company Rubicon Research Ltd has been officially listed on the National Stock Exchange (NSE).
Rubicon Research | 16/10/2025 | By Dineshwori | 133
Rubicon Research to Launch IPO on 9 October; Price Band Set at INR 461- INR 485 Per Share
Rubicon Research Limited has announced the launch of its initial public offering (IPO) of equity shares with a face value of ?1 each, opening on 9 October 2025. The Anchor Investor bidding date is set for 8 October 2025, while the offer will close on 13 October 2025.
<br />
Rubicon Research | 07/10/2025 | By Darshana | 260
Rubicon Research Announces Filing of DRHP with SEBI
Rubicon Research Ltd. has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).
Rubicon Research | 01/08/2024 | By Aishwarya | 1460
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy